FOOD AND DRUG ADMINISTRATION (FDA)

First Page		Document Content
Growth factors Pyridines Renal dialysis Erythropoiesis-stimulating agents Orphan drugs Axitinib Renal cell carcinoma Peginesatide Erythropoietin Medicine Chemistry Organic chemistry		FOOD AND DRUG ADMINISTRATION (FDA) Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 98,31 KB Share Document on Facebook

	Omontys approved for anemic people with kidney disease DocID: QF1h - View Document
	HEMATOPOIETIC AGENTS CRITERIA Pharmacology: Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid DocID: MhOC - View Document
	Date Dear Physician I am writing to make you aware that the Public Employees Insurance Agency (PEIA) will be implementing a “Procrit® First” policy for treating patients with anemia effective May 1, 2009. Epoetin a DocID: Hvu1 - View Document
	Peginesatide Affymax, Inc. Briefing Document ODAC Meeting 07 Dec 2011 DocID: Gg5C - View Document
	Microsoft PowerPoint - Additional Slides Shown[removed] DocID: FaSG - View Document